Gap junctions in human glioblastomas: implications for suicide gene therapy

Area of Science:

• Neuro-oncology
• Molecular Biology
• Cellular Biology

Background:

• Glioblastoma is an aggressive astrocytic tumor with poor prognosis.
• Suicide gene therapy, using herpes simplex virus thymidine kinase and ganciclovir, is a promising treatment strategy.
• Functional gap junctions are crucial for the efficacy of this therapy, and Connexin 43 (Cx43) is a key component in astrocytes.

Purpose of the Study:

• To investigate the expression and localization of Connexin 43 (Cx43) in human glioblastoma samples.
• To assess the impact of Cx43 expression and localization on gap junction intercellular communication.
• To evaluate the bystander effect in glioblastoma cells following suicide gene therapy.

Main Methods:

• Immunofluorescence analysis of Cx43 expression in 74 human glioblastoma samples.
• Establishment and characterization of eight primary glioblastoma cell cultures.
• Assessment of gap junction intercellular communication and bystander effect in cell cultures.

Main Results:

• Cx43 expression was detected in 77% of glioblastoma samples, exhibiting heterogeneity (unaltered, reduced, or lost).
• Aberrant cytoplasmic localization of Cx43 was observed in primary glioblastoma cultures, reducing intercellular communication by 50-75%.
• The bystander effect of suicide gene therapy was present in all Cx43-positive cultures, irrespective of Cx43 localization.

Conclusions:

• Glioblastoma exhibits heterogeneous Cx43 expression and potential for aberrant Cx43 localization.
• Despite altered Cx43 localization, the bystander effect in suicide gene therapy remains viable.
• Findings have implications for designing glioblastoma therapies leveraging the gap junction-mediated bystander effect.